Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample

NCT05322954 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT05322954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05322954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 1
Overall status
Terminated
Start date
March 3, 2023
Completion date
March 7, 2024
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemically-induced disorders, methamphetamine use disorder, stimulant-use disorder, substance use disorders, substance-related disorders